Related Experiment Video
Updated: May 21, 2026

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Mixed cerebrovascular disease and the future of stroke prevention
Insights
Stroke prevention needs to address mixed cerebrovascular disease, encompassing both ischemic and hemorrhagic conditions. This unified approach aids risk stratification and identifies therapies like PDE inhibitors for comprehensive stroke care.
Area of Science:
- Neurology
- Cerebrovascular Disease Research
- Pharmacology
Background:
- Current stroke prevention strategies often focus narrowly on either ischemic or hemorrhagic stroke.
- This singular focus is insufficient due to the common co-occurrence of both ischemic and hemorrhagic conditions in patients.
- This co-occurrence, termed mixed cerebrovascular disease, necessitates a more integrated approach to prevention and treatment.
Purpose of the Study:
- To introduce and advocate for the concept of "mixed cerebrovascular disease" as a unifying framework for stroke prevention.
- To highlight the clinical and subclinical syndromes encompassed by mixed cerebrovascular disease.
- To explore potential therapeutic strategies, such as phosphodiesterase (PDE) inhibitors, for managing this complex condition.
Main Methods:
- Review and synthesis of existing literature on ischemic and hemorrhagic stroke.
- Identification of clinical and subclinical syndromes associated with mixed cerebrovascular disease.
- Exploration of animal models for understanding hemorrhagic cerebrovascular disease mechanisms.
- Evaluation of therapeutic agents, specifically PDE inhibitors, for their dual-action potential.
Main Results:
- Mixed cerebrovascular disease includes conditions like ischemic stroke, subclinical infarcts, leukoaraiosis, intracerebral hemorrhage, and cerebral microbleeds.
- Recognizing mixed cerebrovascular disease can improve risk stratification for hemorrhagic complications from antiplatelet and anticoagulant therapies.
- Animal models of cerebral amyloid angiopathy and hypertension provide insights into hemorrhagic stroke mechanisms.
- Phosphodiesterase (PDE) inhibitors show promise due to their ability to target both platelets and the vessel wall.
Conclusions:
- A "mixed cerebrovascular disease" framework offers a more comprehensive approach to stroke prevention than focusing on single stroke types.
- This framework aids in assessing risks associated with antithrombotic therapies.
- Targeting mechanisms underlying mixed cerebrovascular disease, potentially with agents like PDE inhibitors, is crucial for effective stroke prevention.
Abstract:
Stroke prevention efforts typically focus on either ischemic or hemorrhagic stroke. This approach is overly simplistic due to the frequent coexistence of ischemic and hemorrhagic cerebrovascular disease. This coexistence, termed "mixed cerebrovascular disease", offers a conceptual framework that appears useful for stroke prevention strategies. Mixed cerebrovascular disease incorporates clinical and subclinical syndromes, including ischemic stroke, subclinical infarct, white matter disease of aging (leukoaraiosis), intracerebral hemorrhage, and cerebral microbleeds. Reliance on mixed cerebrovascular disease as a diagnostic entity may assist in stratifying risk of hemorrhagic stroke associated with platelet therapy and anticoagulants. Animal models of hemorrhagic cerebrovascular disease, particularly models of cerebral amyloid angiopathy and hypertension, offer novel means for identifying underlying mechanisms and developing focused therapy. Phosphodiesterase (PDE) inhibitors represent a class of agents that, by targeting both platelets and vessel wall, provide the kind of dual actions necessary for stroke prevention, given the spectrum of disorders that characterizes mixed cerebrovascular disease.
Related Concept Videos
Hemorrhagic Stroke ll: Pathophysiology
Ischemic Stroke ll: Pathophysiology
Ischemic Stroke l: Introduction
Hemorrhagic Stroke l: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Regulation of Stroke Volume
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
